Access our annual reports and other disclosures from prior years.

Annual Report

Our Annual Report, filed with the SIX Swiss Exchange, provides a comprehensive overview of Novartis, including our corporate governance, compensation practices, and operating and financial results.

Annual Report 2024 (PDF 3.5 MB)

Annual Report 2023 (PDF 3.7 MB)

Annual Report 2022 (PDF 3.9 MB)

English (PDF 3.4 MB)

English (PDF 3.6 MB)

English (PDF 4.0 MB)

English (PDF 3.8 MB)

English (PDF 8.6 MB) | Deutsch (PDF 9.1 MB)

English (PDF 6.8 MB) | Deutsch (PDF 6.9 MB)

English (PDF 9.6 MB) | Deutsch (PDF 9.3 MB)

English (PDF 8.7 MB) | Deutsch (PDF 8.9 MB)

English (PDF 8.7 MB) | Deutsch (PDF 8.9 MB)

Addendum to the Compensation Report (PDF 0.1 MB)

English (PDF 6.7 MB) | Deutsch (PDF 6.7 MB)

Annual Report photography and films

Yoseline's story — USA

The right to sight — Ukraine

A spark of light — Kenya

A strong will of life — China

My whole world — China

A hole in the heart — India

English (PDF 7.7 MB) | Deutsch (PDF 7.7 MB)

Healthcare perspectives by photojournalist Eugene Richards

Life in a Circle: Juan Mejía Miranda is a father donating his kidney to his daughter.

The Villages Miles Away: Shiwaga Hagos is a health extension worker in Ethiopia.

A Gift for Living: Joe Crisman is a former teacher living with multiple sclerosis.

English (PDF 2.8 MB) | Deutsch (PDF 2.8 MB) | Français (PDF 2.8 MB)

English | Deutsch | Français

English | Deutsch | Français

English (PDF 3.7 MB) | Deutsch (PDF 3.7 MB) | Français (PDF 3.7 MB)

English (PDF 2.5 MB) | Deutsch (PDF 3.6 MB) | Français (PDF 3.8 MB)

English (PDF 1.7 MB) | Deutsch (PDF 1.8 MB) | Français (PDF 1.7 MB)

English (PDF 2.8 MB) | Deutsch (PDF 2.8 MB) | Français (PDF 2.4 MB)

Form 20-F

Novartis results in line with requirements of the US Securities and Exchange Commission (SEC).

Form 20-F 2024 (PDF 3.4 MB)

Form 20-F 2023 (PDF 3.5 MB)

Form 20-F/A 2022 (PDF 3.8 MB)

English (PDF 3.4 MB)

View Amendment No. 1 to Novartis Form 20-F for 2021 (dated April 26, 2022 | PDF 0.2 MB)

English (PDF 3.4 MB)

English (PDF 4.1 MB)

English (PDF 3.9 MB)

English (PDF 4.2 MB)

English (PDF 2.9 MB)

English (PDF 9.1 MB)

English (PDF 2.5 MB)

English (PDF 9.6 MB)

English (PDF 2.0 MB)

English (PDF 2.0 MB)

English (PDF 1.6 MB)

English (PDF 1.4 MB)

English (PDF 1.1 MB)

English (PDF 1.4 MB)

English (PDF 1.8 MB)

English (PDF 1.4 MB)

English (PDF 2.0 MB)

Novartis in Society

Published from 2021 to 2024, the Novartis in Society Integrated Report covered our business, strategy and performance, including progress against our environmental, social and governance targets. It superseded the Novartis in Society ESG report (formerly our Corporate Responsibility Report), which was published until 2020.​

Novartis In Society Integrated Report: English (PDF 5.0 MB) | Deutsch (PDF 4.7 MB)

Novartis In Society Integrated Report: English (PDF 8.4 MB) | Deutsch (PDF 7.2 MB)

Novartis In Society Integrated Report: English (PDF 8.8 MB) | Deutsch (PDF 7.8 MB)

Novartis In Society Integrated Report: English (PDF 7.7 MB) | Deutsch (PDF 7.7 MB)

Novartis in Society ESG Report (PDF 6.0 MB)

Novartis in Society ESG Report 2019 (PDF 6.3 MB)

Novartis in Society ESG Report 2018 (PDF 3.2 MB)

Other ESG Publications

Archives of other non-financial corporate publications about our business.